Haemonetics Corporation (HAE) DCF Valuation

Haemonetics Corporation (HAE) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Haemonetics Corporation (HAE) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment choices with the Haemonetics Corporation (HAE) DCF Calculator! Utilize actual financial data from Haemonetics, adjust growth projections and expenses, and instantly observe how these alterations affect the intrinsic value of Haemonetics Corporation (HAE).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue 988.5 870.5 993.2 1,168.7 1,309.1 1,413.3 1,525.8 1,647.2 1,778.3 1,919.9
Revenue Growth, % 0 -11.94 14.1 17.67 12.01 7.96 7.96 7.96 7.96 7.96
EBITDA 264.2 142.3 178.5 249.3 265.6 290.2 313.3 338.2 365.2 394.2
EBITDA, % 26.73 16.34 17.97 21.34 20.29 20.53 20.53 20.53 20.53 20.53
Depreciation 110.3 84.3 97.7 93.3 97.2 130.3 140.7 151.8 163.9 177.0
Depreciation, % 11.16 9.68 9.84 7.98 7.43 9.22 9.22 9.22 9.22 9.22
EBIT 154.0 58.0 80.8 156.0 168.4 159.9 172.6 186.4 201.2 217.2
EBIT, % 15.57 6.66 8.13 13.35 12.86 11.32 11.32 11.32 11.32 11.32
Total Cash 137.3 192.3 259.5 284.5 178.8 283.0 305.5 329.8 356.1 384.4
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 165.2 127.6 159.4 179.1 206.6
Account Receivables, % 16.71 14.65 16.05 15.33 15.78
Inventories 270.3 322.6 293.0 259.4 317.2 396.7 428.2 462.3 499.1 538.9
Inventories, % 27.34 37.06 29.5 22.19 24.23 28.07 28.07 28.07 28.07 28.07
Accounts Payable 50.7 50.3 58.4 63.9 73.4 78.7 85.0 91.8 99.1 107.0
Accounts Payable, % 5.13 5.78 5.88 5.47 5.6 5.57 5.57 5.57 5.57 5.57
Capital Expenditure -48.8 -37.0 -96.5 -110.2 -66.3 -94.4 -101.9 -110.0 -118.8 -128.2
Capital Expenditure, % -4.93 -4.26 -9.72 -9.43 -5.06 -6.68 -6.68 -6.68 -6.68 -6.68
Tax Rate, % 22.59 22.59 22.59 22.59 22.59 22.59 22.59 22.59 22.59 22.59
EBITAT 135.2 63.2 55.0 127.3 130.3 132.7 143.3 154.7 167.0 180.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -188.0 95.3 62.1 129.9 85.4 79.2 139.1 150.1 162.1 175.0
WACC, % 5.62 5.71 5.47 5.57 5.54 5.58 5.58 5.58 5.58 5.58
PV UFCF
SUM PV UFCF 591.1
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 182
Terminal Value 11,500
Present Terminal Value 8,765
Enterprise Value 9,356
Net Debt 629
Equity Value 8,727
Diluted Shares Outstanding, MM 51
Equity Value Per Share 169.79

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to generate various scenarios.
  • Real-World Data: Haemonetics Corporation’s financial data pre-filled to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
  • Customizable and Professional: A refined Excel model that adapts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for testing projections, validating strategies, and saving time.

Key Features

  • 🔍 Real-Life HAE Financials: Pre-filled historical and projected data for Haemonetics Corporation.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Haemonetics’ intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Haemonetics’ valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • 1. Access the Template: Download the Excel file containing Haemonetics Corporation’s (HAE) preloaded financial data.
  • 2. Modify Assumptions: Adjust key parameters such as growth rates, WACC, and capital expenditures.
  • 3. Analyze Results Instantly: The DCF model automatically computes intrinsic value and NPV in real-time.
  • 4. Explore Scenarios: Evaluate various forecasts to assess different valuation results.
  • 5. Present with Assurance: Deliver expert valuation insights to enhance your decision-making process.

Why Choose This Calculator for Haemonetics Corporation (HAE)?

  • Accuracy: Utilizes real Haemonetics financial data for precise calculations.
  • Flexibility: Allows users to easily test and adjust inputs as needed.
  • Time-Saving: Eliminate the need to construct a DCF model from the ground up.
  • Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
  • User-Friendly: Intuitive interface suitable for users with varying levels of financial modeling experience.

Who Should Use Haemonetics Corporation (HAE)?

  • Healthcare Investors: Make informed investment choices with a comprehensive analysis of Haemonetics' market position.
  • Medical Financial Analysts: Utilize a streamlined valuation model tailored for healthcare sector analysis.
  • Consultants: Efficiently modify the framework for client reports or presentations related to Haemonetics.
  • Healthcare Enthusiasts: Enhance your knowledge of the medical device industry through real-life case studies.
  • Educators and Students: Apply it as a practical resource in healthcare finance and investment courses.

What the Template Contains

  • Pre-Filled DCF Model: Haemonetics Corporation’s financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Haemonetics Corporation’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.